Other players like Abbott Labs ( ABT), Merck ( MRK) and Johnson & Johnson ( JNJ) are also in the Hep-C race, but those companies are too huge for a single new drug to move the needle. Another player is Vertex Pharmaceuticals ( VRTX), but that company's drug is too early in development to be a major player at the moment. That leaves Gilead Sciences ( GILD), said Cramer, a company that's trading at just 13.5 times earnings with a 16% growth rate. Gilead's drug, currently known as the catchy GS-7977, is in the same family as Bristol-Myers' drug, only without the side effects. The treatment is a 12-week oral regiment, compared to a 24-week injection routine, and the cure rates are, so far, markedly higher. Cramer said Gilead is a lot more than just GS-7977. however. The company also leads the way in HIV treatments and has a host of other promising drugs in the pipeline.
Here's what Cramer had to say about callers' stocks during the "Lightning Round": Cabot Oil & Gas ( COG): "I'd rather wait for a pullback. I say hold off and wait." Advanced Micro Devices ( AMD): "Why? I have nothing to say about those guys. I don't want to touch it." International Business Machines ( IBM): "I say take some profits in IBM and let the rest run." Frontier Communications ( FTR): "The business fell off. They were too confident in their business and I don't like the stock because of that." Main Street Capital ( MAIN): "This one is on fire. I think the stock is a good one." Ecopetrol SA ( EC): "That's a pretty good, well-run company. I think it's better than Total SA ( TOT)."
Am I Diversified?
In the "Am I Diversified" segment, Cramer spoke with callers and responded to tweets sent via Twitter to @JimCramer to see if investors' portfolios have what it takes for today's markets. The first portfolio included: Coca-Cola ( KO), McDonald's ( MCD), Amazon.com ( AMZN), Apple ( AAPL) and Kraft Foods ( KFT). Cramer said this portfolio was properly diversified. The second portfolio's top holdings included: WellPoint ( WLP), McDonald's ( MCD), MGIC Investment ( MTG), Joy Global ( JOY) and Excelon ( EXC). Cramer said he was also bullish on this portfolio's diversification.